Recomendaciones para el tratamiento del Paro Cardiorrespiratorio en pacientes adultos con COVID-19

Contenido principal del artículo

Judith Sagardia
http://orcid.org/0000-0001-9911-7468

Resumen

El virus SARS-CoV-2 causante de la Enfermedad por Coronavirus-2019 (COVID-19), es altamente transmisible a través de gotas (partículas relativamente grandes que se depositan en el aire) y por contacto directo con el paciente o superficies contaminadas (fómites). Si bien la gran mayoría de los casos son leves e incluso muchos de ellos oligosintomáticos, series de casos reportan que un 5% de los pacientes desarrolla enfermedad grave incluyendo síndrome de distrés respiratorio agudo, el cual puede comprometer severamente la oxigenación tisular y llevar al
paro cardiaco (PCR)

Detalles del artículo

Cómo citar
1.
Sagardia J. Recomendaciones para el tratamiento del Paro Cardiorrespiratorio en pacientes adultos con COVID-19. Rev Arg de Ter Int. [Internet]. 13 de abril de 2020 [citado 21 de noviembre de 2024];:21-6. Disponible en: https://revista.sati.org.ar/index.php/MI/article/view/691
Sección
Revisiones Científicas de Comité

Citas

Ferioli M, Cisternino C, Leo V, Pisani L, Palange P, Nava S. Protecting healthcare workers from SARS-CoV-2 infection: practical indications.Eur Respir Rev. 2020;29(155):200068.
Du R-H, Liu L-M, Yin W, et al. Hospitalization and Critical Care of 109 Decedents with COVID-19 Pneumonia in Wuhan, China. Ann Am Thorac Soc. April 2020:AnnalsATS.202003-225OC.
Liao X, Wang B, Kang Y. Novel coronavirus infection during the 2019–2020 epidemic: preparing intensive care units— the experience in Sichuan Province, China. Intensive Care Med. 2020;46(2):357-360.
Cook TM, El-Boghdadly K, McGuire B, McNarry AF, Patel A, Higgs A. Consensus guidelines for managing the airway in patients with COVID-19. Anaesthesia. April 2020. doi:10.1111/anae.15054
van Doremalen N, Bushmaker T, Morris DH, et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. March 2020.
Fritz Z, Perkins GD. Cardiopulmonary resuscitation after hospital admission with covid-19. BMJ. 2020;369:m1387.
Ministerio de Salud - Republica Argentina. COVID-19: Definición de caso. https://www.argentina.gob.ar/salud/coronavirus-COVID-19/definicion-de-caso.Published2020. Accessed April 8, 2020.
Centers for Disease Control and Prevention. Strategies for Optimizing the Supply of Facemasks: COVID-19 | CDC. https://www.cdc.gov/coronavirus/2019-ncov/hcp/ppe strategy/facemasks.html. Published 2020. Accessed April 8, 2020.
Nolan J, Soar J, Eikeland H. The chain of survival. Resuscitation. 2006;71(3):270-271.
Link MS, Berkow LC, Kudenchuk PJ, et al. Part 7: Adult Advanced Cardiovascular Life Support. Circulation.2015;132(18 suppl 2):S444-S464.
American Heart Association. Interim Guidance for Healthcare Providers during COVID-19 Outbreak. Vol 2. Dallas, Tx.; 2020.
International Liaison Committee on Resuscitation. COVID-19 Infection Risk to Rescuers from Patients in Cardiac Arrest. Geneva; 2020.
Mahase E, Kmietowicz Z. Covid-19: Doctors are told not to perform CPR on patients in cardiac arrest. BMJ. 2020;368:m1282.
Kleinman ME, Goldberger ZD, Rea T, et al. 2017 American Heart Association Focused Update on Adult Basic Life Support and Cardiopulmonary Resuscitation Quality: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2018;137(1).
Solomon RS, Corwin GS, Barclay DC, Quddusi SF, Dannenberg MD. Effectiveness of rapid response teams on rates of in-hospital cardiopulmonary arrest and mortality: A systematic review and meta-analysis. J Hosp Med. 2016;11(6):438-445.